Caplin Point to discuss Q2 and H1 FY2026 results

Caplin Point Laboratories Limited announced its board of directors will meet on Wednesday, November 5, 2025, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025. This includes both standalone and consolidated results.

Following the board meeting, the company will host an earnings conference call for analysts and investors on Thursday, November 6, 2025, at 16:00 IST. The call will discuss the financial performance for Q2 & H1 FY2026 and provide a business outlook.

The management team, including chairman C.C. Paarthipan and managing director Dr. Sridhar Ganesan, will represent the company. The trading window for designated persons and their immediate relatives remains closed from October 1, 2025, until November 7, 2025.